Cardiogenic shock: therapy and prevention (Q30471777)

21 June 2017

1 reference

title

Cardiogenic shock: therapy and prevention (English)

1 reference

21 June 2017

1 reference

2

I J Sarembock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

author name string

W L Barry

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

publication date

1 February 1998

1 reference

21 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

page(s)

72-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations.

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

Tailored thrombolytic therapy. A perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

21 January 2018

1 reference

12 December 2020

Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

1 reference

12 December 2020

Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management.

1 reference

12 December 2020

Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia

1 reference

12 December 2020

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction

1 reference

12 December 2020

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

12 December 2020

In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group

1 reference

12 December 2020

Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival

1 reference

12 December 2020

Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

1 reference

12 December 2020

The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction

1 reference

12 December 2020

Relation of size of transmural acute myocardial infarct to mode of death, interval between infarction and death and frequency of coronary arterial thrombus

1 reference

12 December 2020

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

12 December 2020

Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial

1 reference

12 December 2020

Role of right ventricular infarction in cardiogenic shock associated with inferior myocardial infarction

1 reference

12 December 2020

Progressive nature of myocardial injury in selected patients with cardiogenic shock

1 reference

12 December 2020

Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock

1 reference

12 December 2020

Value of early two dimensional echocardiography in patients with acute myocardial infarction

1 reference

12 December 2020

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

12 December 2020

Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatment

1 reference

12 December 2020

Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty

1 reference

12 December 2020

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Cardiogenic shock: Current understandings and future research directions

1 reference

12 December 2020

Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction

1 reference

12 December 2020

Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. Evidence for recovery from near fatal myocardial stunning

1 reference

12 December 2020

Right ventricular infarction

1 reference

12 December 2020

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. The left main shock syndrome

1 reference

12 December 2020

Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy

1 reference

12 December 2020

Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction

1 reference

12 December 2020

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

12 December 2020

Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock

1 reference

12 December 2020

Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction

1 reference

12 December 2020

Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group

1 reference

12 December 2020

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

1 reference

12 December 2020

Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210203

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960210203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json

15 May 2020

9491944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656024&resulttype=core&format=json